You are here

trastuzumab

Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar

Pharmaceutical Business Review

Thu, 12/9/21 - 10:57 am

Prestige BioPharma

Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

CP Wire

Fri, 06/1/18 - 10:10 am

Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe

CP Wire

Thu, 05/3/18 - 09:33 am

FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin

Mon, 04/23/18 - 09:25 am

Key FDA Regulatory Events to Watch Out for in Sep 2017

Yahoo/Zacks.com

Mon, 09/4/17 - 10:31 pm

PTC Therapeutics

Biocon to start selling breast cancer drug in India in February

Yahoo/Reuters

Sat, 01/18/14 - 11:21 am

Biosimilars Could Be An Unlikely Boost For Pfizer

Seeking Alpha

Wed, 04/3/13 - 10:46 am

After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen

Seeking Alpha

Mon, 03/11/13 - 11:09 am

ImmunoGen, Surprisingly Quiet Ahead Of FDA Decision

Seeking Alpha

Thu, 02/14/13 - 11:17 am

This Cancer Drug Works, but Indication Drama Remains

Motley Fool

Sat, 03/31/12 - 12:17 pm

Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab

Pipeline Review

Sun, 03/25/12 - 12:39 pm

Synthon Pharmaceuticals

T-DM1 Significantly Improved Progression-Free Survival Compared to Standard of Care for Previously Untreated HER2-Positive Metastatic Breast Cancer

Yahoo/GlobeNewswire

Sun, 09/25/11 - 12:57 pm

ImmunoGen's Hot Start

Motley Fool

Sat, 04/9/11 - 10:56 am

ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer

Yahoo/BusinessWire

Sat, 12/11/10 - 11:48 am